...
smti-img

Sanara Medtech Inc, Common Stock

SMTI

NAQ

$33.093

-$0.9

(-2.65%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$297.11M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
14.42K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.56
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$26 L
$43.25 H
$33.093

About Sanara Medtech Inc, Common Stock

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameSMTISectorS&P500
1-Week Return-7.18%-3.39%0.2%
1-Month Return-3.9%-1.92%2.72%
3-Month Return4.1%-10.54%7.31%
6-Month Return17.13%-4.47%10.44%
1-Year Return-9.63%4.06%27.53%
3-Year Return28.12%0.94%30.88%
5-Year Return139.37%36.67%89.21%
10-Year Return466.5%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue11.77M15.59M24.14M45.84M64.99M[{"date":"2019-12-31","value":18.11,"profit":true},{"date":"2020-12-31","value":23.98,"profit":true},{"date":"2021-12-31","value":37.15,"profit":true},{"date":"2022-12-31","value":70.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue1.21M1.62M2.31M6.36M7.85M[{"date":"2019-12-31","value":15.4,"profit":true},{"date":"2020-12-31","value":20.59,"profit":true},{"date":"2021-12-31","value":29.43,"profit":true},{"date":"2022-12-31","value":81,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit10.56M13.97M21.83M39.48M57.14M[{"date":"2019-12-31","value":18.48,"profit":true},{"date":"2020-12-31","value":24.45,"profit":true},{"date":"2021-12-31","value":38.21,"profit":true},{"date":"2022-12-31","value":69.1,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin89.72%89.63%90.43%86.12%87.92%[{"date":"2019-12-31","value":99.22,"profit":true},{"date":"2020-12-31","value":99.12,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.24,"profit":true},{"date":"2023-12-31","value":97.22,"profit":true}]
Operating Expenses13.19M18.97M29.21M51.71M61.13M[{"date":"2019-12-31","value":21.57,"profit":true},{"date":"2020-12-31","value":31.04,"profit":true},{"date":"2021-12-31","value":47.78,"profit":true},{"date":"2022-12-31","value":84.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(2.63M)(5.00M)(7.38M)(12.23M)(4.22M)[{"date":"2019-12-31","value":-263005700,"profit":false},{"date":"2020-12-31","value":-500461300,"profit":false},{"date":"2021-12-31","value":-737615700,"profit":false},{"date":"2022-12-31","value":-1223243400,"profit":false},{"date":"2023-12-31","value":-421515300,"profit":false}]
Total Non-Operating Income/Expense(311.64K)577.94K(618.35K)(1.70M)(697.79K)[{"date":"2019-12-31","value":-53.92,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-106.99,"profit":false},{"date":"2022-12-31","value":-294.96,"profit":false},{"date":"2023-12-31","value":-120.74,"profit":false}]
Pre-Tax Income(2.84M)(4.45M)(7.99M)(13.94M)(4.44M)[{"date":"2019-12-31","value":-283577800,"profit":false},{"date":"2020-12-31","value":-444514500,"profit":false},{"date":"2021-12-31","value":-799379500,"profit":false},{"date":"2022-12-31","value":-1393712400,"profit":false},{"date":"2023-12-31","value":-443990200,"profit":false}]
Income Taxes94.43K(62.35K)(688.10K)(5.84M)(136.71K)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-66.04,"profit":false},{"date":"2021-12-31","value":-728.71,"profit":false},{"date":"2022-12-31","value":-6189.75,"profit":false},{"date":"2023-12-31","value":-144.77,"profit":false}]
Income After Taxes(2.93M)(4.38M)(7.31M)(8.09M)(4.30M)[{"date":"2019-12-31","value":-293020500,"profit":false},{"date":"2020-12-31","value":-438279000,"profit":false},{"date":"2021-12-31","value":-730569800,"profit":false},{"date":"2022-12-31","value":-809232800,"profit":false},{"date":"2023-12-31","value":-430319700,"profit":false}]
Income From Continuous Operations(2.84M)(4.45M)(7.99M)(8.09M)(8.34M)[{"date":"2019-12-31","value":-283577800,"profit":false},{"date":"2020-12-31","value":-444514500,"profit":false},{"date":"2021-12-31","value":-799379500,"profit":false},{"date":"2022-12-31","value":-809232800,"profit":false},{"date":"2023-12-31","value":-834094300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(2.93M)(4.38M)(7.31M)(8.09M)(4.30M)[{"date":"2019-12-31","value":-293020500,"profit":false},{"date":"2020-12-31","value":-438279000,"profit":false},{"date":"2021-12-31","value":-730569800,"profit":false},{"date":"2022-12-31","value":-809232800,"profit":false},{"date":"2023-12-31","value":-430319700,"profit":false}]
EPS (Diluted)(1.33)(0.79)(1.08)(1.39)(0.52)[{"date":"2019-12-31","value":-133,"profit":false},{"date":"2020-12-31","value":-79,"profit":false},{"date":"2021-12-31","value":-108,"profit":false},{"date":"2022-12-31","value":-139,"profit":false},{"date":"2023-12-31","value":-52,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SMTI
Cash Ratio 1.14
Current Ratio 2.23
Quick Ratio 2.02

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SMTI
ROA (LTM) -5.08%
ROE (LTM) -20.28%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SMTI
Debt Ratio Lower is generally better. Negative is bad. 0.55
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.45

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SMTI
Trailing PE NM
Forward PE NM
P/S (TTM) 3.81
P/B 7.47
Price/FCF 146
EV/R 4.01
EV/Ebitda NM

FAQs

What is Sanara Medtech Inc share price today?

Sanara Medtech Inc (SMTI) share price today is $33.093

Can Indians buy Sanara Medtech Inc shares?

Yes, Indians can buy shares of Sanara Medtech Inc (SMTI) on Vested. To buy Sanara Medtech Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SMTI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Sanara Medtech Inc be purchased?

Yes, you can purchase fractional shares of Sanara Medtech Inc (SMTI) via the Vested app. You can start investing in Sanara Medtech Inc (SMTI) with a minimum investment of $1.

How to invest in Sanara Medtech Inc shares from India?

You can invest in shares of Sanara Medtech Inc (SMTI) via Vested in three simple steps:

  • Click on Sign Up or Invest in SMTI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Sanara Medtech Inc shares
What is Sanara Medtech Inc 52-week high and low stock price?

The 52-week high price of Sanara Medtech Inc (SMTI) is $43.25. The 52-week low price of Sanara Medtech Inc (SMTI) is $26.

What is Sanara Medtech Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Sanara Medtech Inc (SMTI) is

What is Sanara Medtech Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Sanara Medtech Inc (SMTI) is 7.47

What is Sanara Medtech Inc dividend yield?

The dividend yield of Sanara Medtech Inc (SMTI) is 0.00%

What is the Market Cap of Sanara Medtech Inc?

The market capitalization of Sanara Medtech Inc (SMTI) is $297.11M

What is Sanara Medtech Inc’s stock symbol?

The stock symbol (or ticker) of Sanara Medtech Inc is SMTI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top